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Abstract
Crotamine, a 42-residue polypeptide derived from the venom of the South American rattlesnake Crotalus durissus terrificus,
has been shown to be a cell-penetrating protein that targets chromosomes, carries plasmid DNA into cells, and shows
specificity for actively proliferating cells. Given this potential role as a nucleic acid-delivery vector, we have studied in detail
the binding of crotamine to single- and double-stranded DNAs of different lengths and base compositions over a range of
ionic conditions. Agarose gel electrophoresis and ultraviolet spectrophotometry analysis indicate that complexes of
crotamine with long-chain DNAs readily aggregate and precipitate at low ionic strength. This aggregation, which may be
important for cellular uptake of DNA, becomes less likely with shorter chain length. 25-mer oligonucleotides do not show
any evidence of such aggregation, permitting the determination of affinities and size via fluorescence quenching
experiments. The polypeptide binds non-cooperatively to DNA, covering about 5 nucleotide residues when it binds to
single (ss) or (ds) double stranded molecules. The affinities of the protein for ss- vs. ds-DNA are comparable, and inversely
proportional to salt levels. Analysis of the dependence of affinity on [NaCl] indicates that there are a maximum of ,3 ionic
interactions between the protein and DNA, with some of the binding affinity attributable to non-ionic interactions.
Inspection of the three-dimensional structure of the protein suggests that residues 31 to 35, Arg-Trp-Arg-Trp-Lys, could
serve as a potential DNA-binding site. A hexapeptide containing this sequence displayed a lower DNA binding affinity and
salt dependence as compared to the full-length protein, likely indicative of a more suitable 3D structure and the presence of
accessory binding sites in the native crotamine. Taken together, the data presented here describing crotamine-DNA
interactions may lend support to the design of more effective nucleic acid drug delivery vehicles which take advantage of
crotamine as a carrier with specificity for actively proliferating cells.
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Introduction
Crotamine is a 42-residue basic polypeptide derived from the
venom of the South American rattlesnake Crotalus durissus terrificus.
[1] As a highly positively-charged polypeptide, it can function as a
cell-penetrating peptide (CPP), crossing the lipid barrier of cellular
membranes. [2–4] CPPs include the Tat protein from HIV-1, the
Antennapedia homeobox protein, and multicationic oligomers
such as polyarginines and polylysines. [4–8] In addition to
traversing the cellular membrane, these peptides can transport
proteins, nucleic acids and perhaps, even entire genes across the
cellular membrane, [2,8–14] suggesting possible theranostic
applications. [15–16] An advantageous feature of CPPs in drug
transduction is that these carriers do not require specific receptors
in the targeted cell membrane.
Crotamine stands out among CPPs for its unique specificity for
actively proliferating (AP) cells. [12,17]. This special property is
one of an increasing number of examples of animal toxins with
potential therapeutic applications. [8,12,17–20] Interestingly,
crotamine displays antimicrobial activity [21–22], and phyloge-
netic analysis indicates that it shares a common ancestry and a
strongly conserved three-dimensional folding pattern with the non-
toxic b-defensin antimicrobial peptides, [23–24].
Crotamine is non-toxic to mouse stem cells and mammalian
cells at low micromolar levels [17,25] and it can be used to
transfect a variety of mammal cells both in vitro and in vivo.
[8,12,17,25] It has been shown to successfully promote the
transfection of bone marrow and other AP cells upon
intraperitoneal injection of the crotamine-DNA complex. [12]
The mechanism by which crotamine or crotamine-DNA
complexes enter cells involves binding to cell-surface heparan
sulfate proteoglycans, followed by endocytosis. [12] When
administered to cells at toxic levels, concentration-dependent
intracellular accumulation of crotamine leads to a subsequent
permeabilization of endosomal/lysosomal vesicles, and protease
leakage that triggers cell death. [25] A recent study demon-
strated a selective cytotoxicity of crotamine toward tumor cells:
treatment with crotamine showed a significant inhibition of
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tumor growth and enhanced survival of melanoma tumor-
bearing mice. [26] Thus, this polypeptide could serve to target
malignant cells in vivo with nucleic acids as the direct drug
agent, or with intracellularly-expressed gene products encoded
by DNA. Recently, selective uptake of crotamine in vivo by AP
cells in tumor bearing mice models was demonstrated. [27].
The ability of crotamine to permeabilize endosomal/lysosomal
vesicles confers an additional and unique advantage to this protein
as a CPP drug carrier. The efficiency of cargo delivery by CPPs in
the absence of endosomolytic drugs is generally severely limited by
their entrapment within endosomes. [14,28–29] Many CPPs also
require covalent linkage of the cargo for delivery into cells,[30–31]
whereas crotamine forms complexes with nucleic acids [12] via
ionic forces and other non-covalent interactions, as will be detailed
in the present work.
Formation of crotamine-DNA complexes was initially indicat-
ed by alterations in the CD spectra of protein-plasmid DNA
mixtures compared to the spectra of each molecule separately,
and also by the loss of DNA electrophoretic mobility in the
presence of crotamine. [12] Given the potential of crotamine as a
DNA-delivery vehicle with additional anti-cancer and anti-
microbial activities, [21] and its ability to bind to the
chromosomal DNA of mammalian cells after internalization,
[12,17] the study of crotamine interaction with nucleic acids is of
major importance. The utility of crotamine as a nucleic acid-
delivery vehicle will likely depend significantly on the affinity of
crotamine for DNA, and the factors that influence this affinity.
As pointed out by Ziegler and Selig, the CPP-DNA binding
affinity must be high enough to stabilize the resulting complex
and promote high transfection, but it also needs to be sufficiently
low in order to facilitate the release of the DNA cargo upon
cellular uptake. [13] We further note that the demonstrated
affinity of crotamine for chromosomal DNA [17] might play an
essential role for efficient delivery of therapeutic genes into the
cell nucleus mediated by this protein.
Herein we describe in detail the binding of crotamine to
single- (ss) and double-stranded (ds) DNAs of different lengths,
base compositions, and structure over a range of ionic
conditions. Agarose gel electrophoresis and ultraviolet spectro-
photometry analysis indicate that crotamine complexes with
long-chain DNAs readily aggregate and precipitate at low ionic
strength. This aggregation becomes less likely with shorter chain
length or increasing ionic strength. The ss- or ds-oligonucleo-
tides containing, respectively, 25 nucleotides or base pairs did
not show any evidence of such aggregation, thus permitting
determination of affinities and site size via fluorescence
quenching experiments. We estimate that when it binds to
ssDNA, crotamine occludes about 5 nucleotide residues, and
about the same number of residues (,2.5 base pairs) upon
interacting with dsDNA. The affinities of the protein for ss- vs.
ds-DNA were comparable and, as expected, decreased with
increasing salt levels. Analysis of the dependence of the affinity
on [NaCl] indicates a maximum of ,3 ionic interactions
between the protein and DNA. A short peptide, Arg-Trp-Arg-
Trp-Lys-Leu-NH2, containing residues 31–35 of crotamine,
corresponding to a potential DNA binding site, bound DNA
with a lower affinity and salt dependence than that of the full
protein. This suggests that crotamine could possess more than
one DNA binding site.
The development of crotamine as an effective drug carrier will
require detailed knowledge of its DNA binding properties, and the
results of this should prove most valuable in this process.
Materials and Methods
Materials
Crotamine was purified from C. durissus terrificus venom as
previously described. [17] The venom was obtained as a gift from
the Faculdade de Medicina de Ribeira˜o Preto (FMRP) serpentar-
ium, Sa˜o Paulo University. Stock solutions of lyophilized protein in
the standard buffer (see below) were kept frozen at 220uC until
use. Protein concentration was determined spectrophotometrically
at 280 nm using the extinction coefficients and composition of the
component aromatic amino acids, Trp, Tyr, and Phe, respectively:
e280 = 265559+1197+0.7 = 1.236104 M21 cm21. Oligonucleo-
tides were obtained from Midland Certified Reagent Company,
Inc. (Midland, TX): KR-2: d(CCG)8C, KR-1: dG(CGG)8, 21+:
d(ATGTGGAAAATCTCTAGCAGT), 21-: d(ACTGCTAGA-
GATTTTCCACAT), (dT)7, (dT)14, and (dT)21. Calf thymus
DNA was purchased from Sigma (type I, estimated by the supplier
to be 10–15 MDa in length).
The synthesis of the Arg-Trp-Arg-Trp-Lys-Leu-NH2 was
carried out manually using standard Fmoc (N-(9-fluorenyl)methox-
ycarbonyl) chemistry [32] on 100 mg of Rink amide resin
(0.7 meq/g; Advanced Chemtech, Louisville, KY, USA). Fmoc-
Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-Trp(Boc)-OH and Fmoc-
Arg(Pbf)-OH (Advanced Chemtech) were used in 2.5-fold molar
excess relative to the nominal resin derivatization. Couplings were
performed by use of HBTU (O-benzotriazole-N,N,N’,N’-tetra-
methyl-uronium hexafluoro-phosphate)/HObt (N-hydroxybenzo-
triazole monohydrate) mixture in presence of N,N’-diisopropy-
lethylamine. Removal of side chain protection and cleavage of the
peptide from the Rink amide resin were simultaneously performed
by using 262 mL trifluoroacetic acid, water, triisopropylsilane,
anisol (88:5:4:3 v/v/v/v) plus 20 mg dithiotreitol for 2 h at room
temperature. The crude peptide solution thus obtained was
concentrated under vacuum to an oily residue which was then
extracted four times with 5 mL of cold t-butyl methyl ether to
remove reaction by-products. Further purification was performed
by applying the crude peptide dissolved in 10 mL of 0.15 M NaCl
solution buffered with 0.03 M Tris-Cl, pH 8.1, into a 1640 cm
column of CM-Sepharose FF (Amersham Biosciences) equilibrated
with sample buffer and developed with a NaCl gradient up to 1 M.
The material corresponding to the latest eluting A280 nm peak was
characterized by amino acid analysis after acid hydrolysis, [33]
indicating a peptide whose composition had the molar ratio Leu
(1.0), Lys (1.2), Trp (2.0) and Arg (1.8) and an overall yield of 22%.
Aliquots of purified peptide were desalted by reverse phase
chromatography in C-18 Sep-Pak cartridges (Millipore Co., MA,
USA) and lyophilized.
Unless otherwise stated, the standard buffer used for protein-
DNA binding and aggregation experiments was 0.02 M Hepes,
pH 7.7, 0.0001 M Na2EDTA, and varying levels of NaCl.
Electrophoresis
Electrophoresis experiments utilized TopVision LE GQ Aga-
rose (low electroendosmosis, Fermentas Life Sciences). Unless
otherwise indicated, gels contained 3% (w/v) agarose and were
run in TBE buffer. DNA ladders were obtained from Fermentas
Life Sciences (GeneRuler Low Range, 25–700 bp).
Fluorescence and UV-Visible Spectrometry
Fluorescence titrations were conducted in a SPEX Fluoromax-2
spectrofluorimeter at 2061uC, with excitation set at 295 nm
(2 nm dispersion) and emission at 353 nm (4 nm dispersion). Small
(typically 10 mL) aliquots of nucleic acid were added to 2.5 mL of
crotamine (1.5 mM) in the standard buffer plus [NaCl], where
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indicated. After each addition, the solution was stirred for 20 sec.
In order to account for any loss of fluorescence due to adhesion of
protein to cuvette surfaces, control titrations were performed
where aliquots of the standard buffer were added in the same
volumes as the nucleic acid aliquots, with subsequent stirring. The
displayed fluorescence titrations were adjusted for background
(buffer alone) readings, volume changes, and any changes in
fluorescence seen with the control experiments. All fluorescence
experiments were performed under conditions where absorbance
measurements (performed with 50–100 fold greater concentrations
of DNA and crotamine) indicated that no aggregation would occur
during the course of the titration.
For absorbance measurements, a Cary 100 Bio UV-visible
spectrophotometer was used with 200 mL samples prepared in the
standard buffer at room temperature.
Binding Analysis
Fluorescence quenching experiments were analyzed via the
McGhee-von Hippel non-specific binding model [34] as modified
by Tsodikov et al [35] for finite lattices (in this case, oligonucle-
otides). A non-linear least squares fitting program (NFIT) was used
to determine association constants and binding site size. Use of the
finite lattice model yielded calculated values for association
constant, K, that were slightly (,15%) higher than those values
obtained without the Tsodikov et al modification.
Results and Discussion
Aggregation of Crotamine-DNA Complexes: Effect of
DNA Length and Concentration
Previous results indicated that crotamine readily forms a
complex with plasmid DNA, as evidenced by the severely limited
electrophoretic mobility, or disappearance of the ethidium
bromide-stained DNA in the mixture. [12] In order to determine
the extent of aggregation in these complexes, we have examined
the spectrophotometric and electrophoretic properties of crota-
mine-DNA mixtures. As seen in Figure 1A, mixtures of crotamine
with double-stranded (ds) calf thymus DNA yielded absorbance
readings significantly greater than the sum of the individual
protein and nucleic acid absorbances, with light scattering seen at
320 nm. This suggests that aggregation was occurring. Accord-
ingly, when the mixture was spun in a microfuge for 5 min at
13,200 rpm, the supernatant had lost ,85% of its initial
absorbance at 260 and 280 nm, and no absorbance was observed
at 320 nm (Fig. 1A). An analogous experiment was performed
with a 25-residue single-stranded (ss) oligodeoxynucleotide,
d(CCG)8C. At comparable concentrations (about 25 mM DNA
in nucleotide residues, and 2.5 mM crotamine), no increase at
320 nm occurs when crotamine is mixed with this oligonucleotide
(Fig. 1B).
The observed aggregation may be related to the neutralization
of positive charge on the protein by the negatively-charged
nucleic acid. To test this, we monitored the effect of increasing
levels of crotamine on the A320 readings seen with calf thymus
DNA and with ss- and ds-oligonucleotides. With relatively low
levels of ds calf thymus DNA (16.5 mM residue), 320 nm light
scattering was observed when the [crotamine]:[DNA residue]
exceeded 1:10 (Fig. 1C). At this DNA concentration, the
d(CCG)8C showed little evidence of scattering when crotamine
was added. At a higher concentration (121 mM residue), mixtures
of the 25-mer oligonucleotide and crotamine displayed a more
abrupt increase in scattering, occurring at a [crotamine]:[DNA
residue] of ,1:5 (Fig. 1D). Note that the spectrum of the oligo-
crotamine mixture shown in Fig. 1B was obtained at a
significantly lower DNA level and at a [protein]:[DNA residue]
just below the point in the titration where the A320 sharply
increases. The double-helix of the 25-mers and its complement
also showed an abrupt transition, which occured at a
[crotamine]:[DNA residue] similar to that seen with ds calf
thymus DNA (Fig. 1E).
These results suggest that aggregation is dependent on both
DNA length and concentration. In order to directly assess the
effect of DNA length on aggregation, we utilized agarose
electrophoresis to determine the solubility of mixtures of crotamine
with a dsDNA ladder with lengths varying between 25 and 700
base-pairs (bps). In these experiments, the DNA residue concen-
trations were considerably higher (250 to 500 mM residue) than
the levels used in the spectrophotometric studies, thus increasing
the probability of aggregation (UV spectra of these mixtures
displayed scattering at 320 nm, although less than that observed
with calf thymus DNA; not shown). When a mixture of crotamine
and DNA ladder ([protein]:[DNA residue] = 1:10) was run on 3%
agarose, only the shortest DNA chains (25, 50, and 75 bps) were
seen to enter the gel (Fig. 2A, lane 2). The longer DNA chains
largely remained in the sample well, indicating that they were part
of a large protein-DNA aggregate (lane 2). When treated with
0.1% SDS, all the bands were seen to migrate to their expected
positions, indicating that the aggregate had been effectively broken
up by the detergent (lane 3). When a 1:10 [protein]:[DNA]p
mixture was subjected to a five minute microfuge spin (the ‘‘p’’
refers to nucleotide residue concentration), the supernatant clearly
contained the 25, 50 and 75 bp bands (lane 4), which were
depleted from the SDS-treated precipitate (lane 5).
The presence of increasing amounts of the 50 and 75 bp chains
in the precipitate is in line with the DNA length dependence of
aggregation suggested by the spectrophotometric results. This was
further illustrated by observing the effect of increasing levels of
protein on the electrophoretic mobility of the DNA bands (Fig. 2B).
As the [crotamine]:[DNA] increases, the longest DNA strands are
the first to be removed from the body of the gel. At the highest
[crotamine]:[DNA]p (1:7.5), only the shortest chains (25, 50, 75,
and 100 bps) are visible in the gel. The loss of electrophoretically
mobile DNA bands is clearly a function of ionic strength, since
increasing levels of NaCl were seen to increase the amount and
extent of DNA entering the gel (Fig. 2C). Thus, at 0.10 M NaCl,
bands as long as 400 bp are seen in the supernatant of centrifuged
crotamine-DNA mixtures. As in Fig. 2A, the electrophoretic
patterns of the SDS-treated precipitates show the bands depleted
from the supernatants. When the sample wells were located in the
middle of the gel, no ethidium bromide-stainable material was
seen to migrate towards the negative electrode (data not shown).
Thus, there was no evidence for any positively-charged electro-
phoretic species.
The spectrophotometric and electrophoretic results indicate
that crotamine readily forms precipitable aggregates with both ds
and ss DNA. The probability of aggregation increases with
increasing DNA length, and decreases with increasing ionic
strength. Aggregation is clearly dependent on the [protein]:[DNA
residue] ratio, and the point where this becomes apparent is likely
related to the neutralization of the nucleic acid’s negative charge
by the protein. This is a qualitative measure of the occluded site
size in the complex, i.e., the number of nucleotide residues covered
by each bound protein.
Binding Site Size and Affinities of Crotamine for
Oligonucleotides
In order to directly quantify binding parameters, including
affinities, site size and salt dependence, it is necessary to perform
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experiments under conditions where aggregation does not occur.
Thus, these studies are necessarily restricted to relatively short
DNA molecules where there is no absorbance at 320 nm upon
interaction with the protein. We find that the intrinsic tryptophan
(Trp) fluorescence of crotamine is quenched upon interaction with
ss and ds oligonucleotides. Fluorescence measurements require
only micromolar levels of crotamine, conditions where interacting
oligonucleotides do not form aggregates. The binding parameters
obtained in these experiments, crotamine-DNA association
constants, site sizes, and number of charge interactions associated
with binding apply also to longer DNA molecules. However,
crotamine molecules interacting with the longer DNAs may also
be capable of binding more than one of these substrates (see
below).
Figure 1. Spectrophotometry of crotamine-DNA mixtures in 0.02 M Hepes, pH 7.5, 0.01 M NaCl, 0.0001 M EDTA (standard buffer
with indicated [NaCl]). A. Spectra of 4.161025 M ds calf thymus DNA +4.361026 M crotamine. ––––––, DNA alone; ? ? ? ? ?, crotamine alone; – – – –,
DNA + crotamine prior to centrifuging; – ? – ? – ? –, DNA + crotamine supernatant after centrifuging; – ? ? – ? ? – ? ? –, sum of individual DNA and
crotamine spectra. B. Spectra of 2.561025 M(p) 25-mer (CCG)8C and 2.5610
26 M crotamine. ––––––, DNA alone; ? ? ? ? ?, crotamine alone; – – – –, DNA
+ crotamine. C. Titration of ds calf thymus DNA with crotamine; starting [DNA] = 2.2261025 M(p). D. Titration of d(CCG)8C with crotamine; starting
[DNA] = 1.2161024 M(p). E. Titration of d(CCG)8CNG(CGG)8 with crotamine; starting [DNA] = 6.261025 M(p).
doi:10.1371/journal.pone.0048913.g001
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A typical set of titrations, with the ss 25-mers, d(CCG)8C, is
shown in Fig. 3A. At the lowest salt level, 0.01 M NaCl, the
fluorescence drops nearly linearly with the addition of the DNA,
reaching a maximal quenching of about 60%. This suggests that
under these ionic conditions the binding is close to stoichiometric,
i.e., below the saturation point, nearly all the DNA added binds to
the protein, with only a small amount free in solution. Upon
saturation, the fluorescence no longer drops, so the overall binding
plot approximates two straight lines. The intersection of these lines
is a measure of the occluded binding site size, although it is not a
precise determination. When the experiment is repeated at higher
[NaCl], the plots are shallower and clearly non-linear, indicating
that not all the added DNA binds protein (Fig. 3A). The addition
of aliquots of concentrated NaCl upon completion of the titration
restores most of the initial crotamine fluorescence (Fig. 3B). Under
the conditions of these experiments, 0.0860.01 M [NaCl] is
needed to restore half the initial fluorescence, and therefore
dissociate 50% of the complexes that had been formed.
The data in Fig. 3A was analyzed using the McGhee-von
Hippel model for a ligand (protein) binding in a non-cooperative
fashion to a lattice (DNA), which accounts for the presence of
overlapping binding sites (Fig 4A). [34,36] The occluded site size,
n, was found to be 4.660.2 nucleotide residues per crotamine; the
protein-DNA association constants, K (the affinity of the protein
for an isolated site on the DNA), are listed in Table 1. At
saturation, crotamine-DNA complexes would in principle be
positively-charged, since at neutral pH each protein carries a net
charge of 8+, and the ,5-residue DNA segment to which it is
bound has a charge of 5-. As we noted above, electrophoresis
experiments showed no evidence for positively-charged complexes.
In all likelihood, under the conditions of those experiments (which
were conducted at crotamine concentrations more than 100-fold
higher than the micromolar levels used in the fluorescence studies),
aggregation occurred before saturation could be achieved.
Furthermore, if each crotamine is capable of binding more than
one DNA molecule, which might occur with longer DNAs (see
below), the net charge associated with each bound crotamine
could be negative, given the additional negative charge provided
by the second bound nucleic acid.
The dependence of K on [Na+] follows a linear log-log
relationship, with a slope of 22.260.3 (Fig. 4B). Record and
colleagues have shown that the number of ion pairs, i.e., charge
interactions, involved in the binding of a protein ligand to a
polynucleotide lattice can be calculated from the slope of this log-
log dependence:[37–38].
-L logK=Llog½Naz~kzm0y
where k is the number of anions (in this case Cl-) displaced from
the protein upon binding, m9 is the number of cations (in this case
Na+) displaced from the nucleic acid, and y is the fraction of
counterion bound in the thermodynamic sense per lattice charge
(which is generally 0.7–0.8; i.e., on average, 70–80% of phosphates
are bound to cations in the free DNA). [37] Thus, depending on
the extent of Cl- binding, there are as many as 3 ion pairing
interactions in the crotamine-DNA complex. The extrapolated
value of K at 1 M Na+, 440 M21, is the non-ionic component of
the affinity. [37] We note that the data points in Fig. 5 are
necessarily far from 1 M Na+, which adds to the error in the
quantitation of this value (with the standard deviation of the
extrapolated log K of 60.34, the extrapolated values of K fall
within a range of 200 to 950 M21). Moreover, this estimate is
based on the linearity of the log K vs. log [Na+] plot (Fig. 4B). It has
been observed that the dependence can change at very low ionic
strength, producing curvature in the plot. [39] If the data obtained
at the lowest [Na+] (0.02 M) are excluded, the slope decreases to
23.360.2, which could represent as many as ,4 ion pairs in the
protein-DNA complex, still consistent with the occluded site
determination. The extrapolated value of K at 1 M Na+, where the
affinity is the result of non-ionic interactions, is 32612 M21; a DG
of,22 kcal mol21. This is lower than the value obtained with all
the data points (440 M21, DG , 24 kcal mol21), but does not
Figure 2. DNA length, concentration, and salt dependencies of crotamine-DNA aggregations, in the standard buffer, unless
otherwise indicated. A. Effect of DNA length. Lane 1: DNA ladder; lane 2:1 mg (3 nmol in residue) DNA ladder +0.3 nmol crotamine,
[crotamine]:[DNA]p = 1:10; lane 3: same as lane 2, but treated with SDS (0.1% net) prior to electrophoresis; lane 4: supernatant of mixture as in lane 2
after centrifugation at 13,000 rpm for 5 min; lane 5: precipitate of mixture in lane 4 after treatment with 0.1% SDS. B. Effect of relative DNA
concentration. Each lane contained 0.5 mg DNA ladder. Samples were centrifuged at 13,000 rpm for 5 min, and supernatants applied to the gel. Lane
1: DNA alone. [crotamine]:[DNA]p = 1:30 (lane 2), = 1:20 (lane 3), = 1:15 (lane 4), = 1:12 (lane 5), = 1:10 (lane 6), = 1:7.5 (lane 7). C. Effect of salt. Each lane
contained 1 mg DNA ladder. Lane 1: DNA ladder alone. Lanes 2–7:0.5 mg DNA ladder +0.3 nmol crotamine in 0.01 M NaCl (lane 2: supernatant, lane 3:
SDS-treated precipitate), in 0.05 M NaCl (lane 4: supernatant, lane 5: SDS-treated precipitate), in 0.1 M NaCl (lane 6: supernatant, lane 7: SDS-treated
precipitate).
doi:10.1371/journal.pone.0048913.g002
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change our observation that at least some of the binding is
associated with non-charged residues. Interestingly, it was
estimated that the non-ionic contribution to the interaction of
crotamine with the negatively-charged polysaccharide, heparin, is
also significant: K at 1 M Na+ is about 1700 M21. [12].
Effect of DNA Structure and Length on Affinity for
Crotamine
We have presented data showing that both ds and ss DNA
interact with crotamine. In order to determine if there is any
preference for ds vs. ssDNA, we compared the binding of ss- and
ds-oligonucleotides. The effect of d(CCG)8CN dG(CGG)8 on
crotamine fluorescence in 0.01 M NaCl is shown in Fig. 5, along
with the NaCl-induced ‘‘salt-back’’. The analogous data for
dG(CGG)8 is plotted on the same graphs. The two sets of data are
virtually identical: the maximal extent of quenching is ,30%, and
the complex formed is 50% dissociated at 0.0560.01 M Na+. The
near identity of the titrations indicates that the number of
nucleotide residues covered by each crotamine on dsDNA is the
same as on ssDNA. Thus, crotamine occupies a span of about two
and a half nucleotide pairs, so that about four crotamine molecules
bind within a 10 bp turn of a B-DNA helix. For either ss or
dsDNA, the occluded site size is consistent with the estimate of
#3 ion pairs between each bound crotamine and the DNA
backbone. Note that the half-way point of the d(CCG)8C salt-back
was reached at 0.08 M Na+, and the extent of quenching was
twice what was observed with its complement and the duplex
formed with its complement. These results do not indicate a clear
Figure 3. Binding of d(CCG)8C to crotamine as a function of [NaCl]. A. Fluorescence titrations were performed in the standard buffer (0.02 M
Hepes, pH 7.5, 0.0001 M EDTA) with the following [NaCl]:&, 0.01 M;¤, 0.05 M;%, 0.075 M; m, 0.1 M. B. Reversal of 0.01 M titration by addition of
aliquots of a concentrated solution of NaCl. [Na+] was calculated from the [NaCl] and the contribution of the other components of the buffer. The
lines connect the points and are shown for clarity.
doi:10.1371/journal.pone.0048913.g003
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preference for ss vs. dsDNA, although sequence and/or base
composition might influence binding affinity, and clearly affect the
extent of fluorescence quenching.
With this in mind, we examined the binding of an A-T rich 21-
residue oligomer, d(ATGTGGAAAATCTCTAGCAGT), its
complement, and its duplex with its complement. As seen in
Fig. 6A, the maximal extent of crotamine Trp fluorescence
quenching achieved with both ss oligos is ,65%, similar to the
fluorescence change seen with d(CCG)8C. This is significantly
greater than the quenching seen with the A-T rich duplex, ,40%.
Thus, analogous to d(CCG)8C and its duplex with its complement,
there is a potential for greater quenching with single strands,
raising the possibility that one or both of the protein’s Trp residues
are involved in this interaction (see below). The salt-back data for
the A-T rich oligos (Fig. 6B) show 50% reversals at 0.08, 0.09, and
0.095 M Na+ for, respectively, d(ATGTGGAAAATCTCTAG-
CAGT), its complement, and the duplex. These results are similar
to the salt-reversal seen with d(CCG)8C, but unlike the variations
among the G-C substrates, both A-T rich single strands and their
duplex show essentially the same dependence on [Na+]. Thus,
although there is no general preference for single- vs. double-
strands, DNA sequence, composition, and structure, it seems that
they all can affect the affinity for crotamine.
The effect of oligonucleotide length on crotamine binding was
also examined. In these experiments, oligothymidylates containing
7, 14, and 21 residues were compared (Fig. 7). The three
oligonucleotides showed similar titrations, with the 50% reversal
points at 0.12, 0.11, and 0.10 M Na+ for, respectively, dT7, dT14,
and dT21. Here again, there is no obvious preference for length
within the 60.01 M uncertainty in [Na+] at 50% reversal. The
result is fully consistent with the non-cooperative binding displayed
by the quantitative analysis of the d(CCG)8C binding data, since
with a cooperative interaction the overall affinity would be
significantly boosted with oligonucleotides capable of binding an
increasing number of crotamines. Given that the salt-dependence
is seen to be essentially independent of oligo length, this clearly
Figure 4. Scatchard plots and salt dependence of the data in
Fig. 3. A. Scatchard plot: n ; [crotamine]bound/[total d(CCG)8C]p, L ;
[crotamine]free. The solid lines represent curves calculated from the best
fit of the Tsodikov et al. [35] modification of the McGhee-von Hippel
model for non-cooperative binding ligands [34] (see Materials and
Methods). B. Log-log dependence of the association constants
calculated in panel A on [Na+].
doi:10.1371/journal.pone.0048913.g004
Table 1. Dependence of Crotamine - d(CCG)8C Association
Constants on [NaCl]*.
[NaCl], M [Na+], M K, M21
0.010 0.020 2.160.26106
0.050 0.060 3.160.36105
0.075 0.085 1.160.16105
0.100 0.110 4.360.46104
*Titrations were performed in 0.02 M Hepes, pH. 7.7, 0.0001 M Na2EDTA, and
the indicated concentration of NaCl. The [Na+] includes the contribution from
the buffer (0.01 M).
doi:10.1371/journal.pone.0048913.t001
Figure 5. Comparison of binding of a single-stranded oligonu-
cleotide (d(CCG)8C) to crotamine with the binding of a double-
stranded oligonucleotide (d(CCG)8CNG(CGG)8). A. Fluorescence
titration in the standard buffer with 0.01 M NaCl: %, d(CCG)8C); m,
d(CCG)8CNG(CGG)8. B. NaCl-induced reversal.
doi:10.1371/journal.pone.0048913.g005
DNA-Interactive Properties of Crotamine
PLOS ONE | www.plosone.org 7 November 2012 | Volume 7 | Issue 11 | e48913
does not occur.
Modes of Interaction with DNA
With 11 basic amino acids (9 lysine and 2 arginines) and 5
aromatics (2 tryptophans, 2 phenylalanines, and 1 tyrosine), there
are many ways that nucleic acids could conceivably bind to the
surface of crotamine. One potential binding site is the region
between residues 31 and 35, Arg-Trp-Arg-Trp-Lys. This combi-
nation of alternating basic and aromatic residues is similar to the
sequence of short peptides known to possess significant nucleic
acid binding affinity, with greater affinity for ss than for ds DNA
[40–44]. In the case of crotamine, we have not seen such a
preference. This could be due to the particular geometry of these
residues within the 3D structure of the protein. As seen in Fig. 8,
positioning crotamine within the major groove of the dsDNA B-
helix facilitates backbone phosphate interactions with Arg-31 and
Arg-33. Moreover, Trp-32 is in a position to flip its indole ring into
the groove.
With a view toward establishing the plausibility of this region as
a nucleic acid binding surface, we synthesized the hexapeptide,
Arg-Trp-Arg-Trp-Lys-Leu-NH2, containing the sequence of res-
idues 31–35, and examined its DNA binding properties. At low
salt (0.01 M NaCl), the effect of d(CCG)8C on the peptide’s
tryptophan fluorescence is similar to that seen with the full-length
protein (Fig. 9). However, at increasing salt levels, the binding is
clearly much weaker than it was for the full-length protein. In
0.05 M NaCl, where the protein was saturated by the oligonu-
cleotide at an [oligo]p:[crotamine] of 22:1, a higher [oligo]p:[pep-
tide] (33:1) achieved less than half saturation – even below that
seen for the protein at 0.075 and 0.1 M NaCl (where the peptide
shows less than 25% saturation). This difference is also illustrated
by the salt-back after titration at 0.01 M NaCl (Fig. 9B). Whereas
half-reversal of binding for the full-length protein is achieved at
0.08 M [Na+], the short peptide clearly requires less Na+ to reach
this point (0.06 M). In addition, the reversal seen with the short
peptide occurs over a broader range of [Na+], indicating a weaker
dependence of affinity on [salt]. We also note that in this
comparison, NaCl was added at a higher [oligo]p:[peptide] (33:1)
than for the full-length protein (22:1), which would (by mass
action) have a greater effect on stabilizing complex formation.
Thus, the salt-reversal clearly shows a weaker affinity and salt-
dependence for the peptide.
Compared to the full-length protein, the short peptide will lack
the larger molecule’s 3D structure and have significantly greater
conformational flexibility. This might explain, in part, the
difference in affinity and salt-dependence. In addition, as seen in
Fig. 8, the intact protein offers other potential binding sites for
DNA, which could account for the higher affinity and salt
dependence. Six of the nine lysine residues in crotamine are visible
in Fig. 8. Two are in close proximity to the arginines, but four
(residues 2, 6, 7, and 38) are distal (about 30 A˚ from the Arg-31
and-33). A second DNA, or a cell-surface heparin/heparan sulfate
could conceivably be bound at this second location. An aromatic
residue, Phe-25, is in close proximity to these four lysine residues
(Fig. 8), and, analogous to the potential role of the tryptophan(s),
could contribute to the non-electrostatic component of binding. In
Figure 6. Dependence of binding affinity on oligonucleotide
sequence. A. Fluorescence titration in the standard buffer with 0.01 M
NaCl: q, d(ATGTGGAAAATCTCTAGCAGT) (21+); m, d(ACTGCTAGA-
GATTTTCCACAT) (21-); &, duplex (21+/2). B. NaCl-induced reversal.
doi:10.1371/journal.pone.0048913.g006
Figure 7. Effect of oligonucleotide length on binding affinity. A.
Fluorescence titration in the standard buffer with 0.01 M NaCl: &, dT7;
m, dT14, q, dT21. B. NaCl-induced reversal.
doi:10.1371/journal.pone.0048913.g007
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this regard, as we noted, at least some of the affinity of crotamine
for heparin is the result of non-ionic interactions. [12].
Another consequence of the large number of basic residues (and
small number of acidic amino acids) is the tendency of the protein
to form aggregates when complexed with DNA. With its multiple
potential binding sites, each crotamine is potentially capable of
binding at least two DNA molecules, which, if they are of sufficient
length, could in turn bind additional crotamines. In this manner, a
protein-DNA network would form and grow, eventually leading to
aggregation and precipitation. Although there is no direct
evidence for this phenomenon, the absence of aggregation with
relatively short oligonucleotides is consistent with their inability to
simultaneously bind to more than one crotamine.
The ability of crotamine to bind to multiple negatively-charged
macromolecular substrates, and in turn form aggregates, is likely
to be essential to its functioning as a drug delivery vehicle. The
involvement of cell surface heparan sulfate proteoglycans in the
uptake of crotamine and crotamine-DNA complexes implies
concurrent binding of the DNA and polysaccharide. [12]
Moreover, the transfection and cellular uptake efficiencies of
small arginine-rich peptides complexed with DNA was found to be
a function of the size of the resulting aggregates. [45] Transfection
increased with aggregate size, whereas internalization of the DNA
was more efficient with small complexes. [45] With this in mind,
we are currently investigating the sizes of crotamine-DNA
aggregates and the rates at which they form, with a view to
determining the optimal particle size and incubation times for
DNA delivery into cells.
Conclusions
We have shown that crotamine, a basic polypeptide component
of the venom of the South American rattlesnake, forms aggregates
with DNA molecules longer than , 50 bp. Shorter DNA also
binds the protein, and we have quantified the affinities and site size
of the non-aggregated complexes that form. Complex formation
occurs with both double- and single-stranded DNA, is non-
cooperative, and there is no obvious dependence of binding
parameters on base composition. A detailed analysis of the salt
dependence of binding indicates that as many as 3 ionic
interactions occur between each crotamine polypeptide and its
DNA binding site. With these observations, and inspection of the
three-dimensional structure of crotamine, we have identified a
potential positively-charged DNA-binding surface on crotamine,
residues 31–35, Arg-Trp-Arg-Trp-Lys. A hexapeptide containing
this sequence binds DNA similarly to the full-length protein, but
with a reduced affinity and salt dependence. This result and the
presence of many other basic residues on the protein suggest that
crotamine may interact with DNA in a variety of ways, which
would also facilitate the formation of aggregates. Given the
specificity of crotamine for AP cells, [8,12,17,25] studies of this
nature should prove valuable in the development of effective DNA
drug delivery vehicles.
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